Ignite Creation Date:
2024-05-05 @ 11:36 PM
Last Modification Date:
2024-10-26 @ 10:36 AM
Study NCT ID:
NCT01364493
Status:
COMPLETED
Last Update Posted:
2017-05-09
First Post:
2011-05-31
Brief Title:
A Study to Evaluate the Efficacy and Safety of Trastuzumab in Combination With Capecitabine and Oxaliplatin as First-line Chemotherapy for Inoperable Locally Advanced or Recurrent andor Metastatic Gastric Cancer
Sponsor:
Peking University
Organization:
Peking University
Organization Data
Organization:
Peking University
Class:
OTHER
Study ID:
CGOG1001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Peking University
Lead Sponsor Class:
OTHER
Responsible Party:
Shen Lin
Responsible Party Title:
MD
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Peking University
Old Name:
None
Old Organization:
None